Deletion of complement factor H-related genes CFHR1 and CFHR3 is associated with atypical hemolytic uremic syndrome
about
Atypical hemolytic uremic syndromeClinical features of anti-factor H autoantibody-associated hemolytic uremic syndromeAssociation of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndromeComplement in age-related macular degeneration: a focus on functionPrimary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification CommitteeNew developments in the genetics, pathogenesis, and therapy of IgA nephropathyAtypical hemolytic-uremic syndrome: a case report and literature reviewAn imbalance of human complement regulatory proteins CFHR1, CFHR3 and factor H influences risk for age-related macular degeneration (AMD)Patterns of somatically acquired amplifications and deletions in apparently normal tissues of ovarian cancer patientsComprehensive analysis of Copy Number Variation of genes at chromosome 1 and 10 loci associated with late age related macular degenerationcnvCapSeq: detecting copy number variation in long-range targeted resequencing data.Leptospira interrogans endostatin-like outer membrane proteins bind host fibronectin, laminin and regulators of complementGenetic influences on plasma CFH and CFHR1 concentrations and their role in susceptibility to age-related macular degenerationTranslational mini-review series on complement factor H: genetics and disease associations of human complement factor H.Translational mini-review series on complement factor H: renal diseases associated with complement factor H: novel insights from humans and animals.The complement factor H R1210C mutation is associated with atypical hemolytic uremic syndromePlasma therapy in atypical haemolytic uremic syndrome: lessons from a family with a factor H mutation.Lack of association between polymorphisms in C4b-binding protein and atypical haemolytic uraemic syndrome in the Spanish population.Atypical hemolytic uremic syndrome associated with complement factor H autoantibodies and CFHR1/CFHR3 deficiency.Complement inhibitor eculizumab in atypical hemolytic uremic syndrome.A large family with a gain-of-function mutation of complement C3 predisposing to atypical hemolytic uremic syndrome, microhematuria, hypertension and chronic renal failure.Thrombomodulin mutations in atypical hemolytic-uremic syndrome.Genetics and complement in atypical HUS.Novel developments in thrombotic microangiopathies: is there a common link between hemolytic uremic syndrome and thrombotic thrombocytic purpura?Thrombotic microangiopathy mimicking membranoproliferative glomerulonephritis.Factor I autoantibodies in patients with atypical hemolytic uremic syndrome: disease-associated or an epiphenomenon?Atypical hemolytic uremic syndrome in children: complement mutations and clinical characteristicsRenal transplantation under prophylactic eculizumab in atypical hemolytic uremic syndrome with CFH/CFHR1 hybrid protein.Thrombotic microangiopathy and associated renal disorders.Factor H autoantibodies and deletion of Complement Factor H-Related protein-1 in rheumatic diseases in comparison to atypical hemolytic uremic syndromeComplement factor H-related protein 1 deficiency and factor H antibodies in pediatric patients with atypical hemolytic uremic syndrome.Assesment, treatment and prevention of atypical hemolytic uremic syndrome.Combined complement gene mutations in atypical hemolytic uremic syndrome influence clinical phenotype.Two patients with history of STEC-HUS, posttransplant recurrence and complement gene mutations.Comprehensive genetic analysis of complement and coagulation genes in atypical hemolytic uremic syndrome.Successful treatment of DEAP-HUS with eculizumab.Atypical haemolytic-uraemic syndrome due to heterozygous mutations of CFH/CFHR1-3 and complement factor H 479.A novel atypical hemolytic uremic syndrome-associated hybrid CFHR1/CFH gene encoding a fusion protein that antagonizes factor H-dependent complement regulation.The major autoantibody epitope on factor H in atypical hemolytic uremic syndrome is structurally different from its homologous site in factor H-related protein 1, supporting a novel model for induction of autoimmunity in this disease.The role of ADAMTS-13 activity and complement mutational analysis in differentiating acute thrombotic microangiopathies
P2860
Q21202864-A3D3EE10-71BF-405B-A609-6E897C5216CCQ24606843-9638666C-D444-431A-B78D-64E58661F372Q24634697-D31B1462-648C-4516-BA9A-FFA646D4742EQ24635874-80EAB41F-EFB9-4CD9-B13E-D72A8C245983Q24645726-28F5697F-EC25-4B12-B6AF-5F151438C924Q26786248-7D19A9C9-E45D-426E-AE09-9D95624177DEQ27003863-515F203A-A1C6-47B9-A4AB-15D089C5B120Q28293350-AF71F4EB-9862-4E8C-8DC1-6AFF4907CDF3Q28390831-E315B428-AC6B-4ABB-B799-14FF42866AAEQ28730260-1B28D79B-2F26-44D7-BFA5-29C12437C00CQ30852238-B53E0CE0-E067-4E27-BAEA-1CEAEB066B93Q33305446-3754C31E-7C47-4068-B592-790A8C8B1415Q33356232-B7945899-ECD3-44A5-8D58-362BF8B1BDF5Q33377799-E4BA6EB3-F045-43C3-AFB7-A4EB8485F0E5Q33378236-76B2CAA5-CF4E-4C5B-8F92-6CA153FABF29Q33378469-F24BC5E2-2C43-4CDD-830D-69FF861D1E9EQ33379624-2398DB19-CAEE-4550-8AC8-1FD1C81D5310Q33382404-491F2331-9E40-48EC-B5F8-36BB0C4DFA30Q33385035-2E127BCF-25D5-4161-AD69-15B6D0A53D90Q33385154-CE6566BF-58ED-4F34-98D8-BDBBC8F01B4EQ33385329-C74F556D-21E4-4C3E-AC42-7A187D505993Q33385474-BEDA781F-3A6D-415A-8676-F1005368035CQ33389945-8384B0E9-555F-4237-BA30-5A710E7144B8Q33395774-D4753DC9-B2B6-4C09-882A-D3CDCB43CF94Q33396467-0DD3D9B4-638A-44BB-AD8E-4D0FD77062DBQ33399052-6922A866-0959-4CD6-94D3-A2896FFA3423Q33400211-C7F4D7C9-7C91-4447-A687-8B2D066284E9Q33400705-3C381AC4-8F18-455C-B1D9-A063DB4B5CAEQ33402372-C911BEF8-6674-4A9E-A702-1ADF458F72BEQ33402827-0AB8BFB3-F37C-4BC6-8116-D2A2CCB20BD0Q33404847-B086E010-8014-46FB-95A0-F11596F8C3F5Q33405916-CC6037BD-FB6A-4CA6-9C31-305BF7376B44Q33406025-71FC222F-3881-46FA-9DAB-B19426682CFFQ33408171-8C40D195-E82D-4FC1-91BC-0B97F693648CQ33410276-A385C507-4D14-4BD5-AC18-F52CD0C4691DQ33411577-1F554330-BC4C-4CC9-9352-F49F07CFF193Q33412073-D5CD8FC2-A37B-441B-8E2A-CEA2047C14D8Q33415753-AE39F6EA-371B-4D64-A044-933A01B670F2Q33420213-D76B1D19-3AB8-495B-89C5-6CDF0A6B4D09Q33427495-F48523EB-B846-4D13-9E4A-4BE48C492FD7
P2860
Deletion of complement factor H-related genes CFHR1 and CFHR3 is associated with atypical hemolytic uremic syndrome
description
2007 nî lūn-bûn
@nan
2007 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մարտին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Deletion of complement factor ...... ical hemolytic uremic syndrome
@ast
Deletion of complement factor ...... ical hemolytic uremic syndrome
@en
Deletion of complement factor ...... ical hemolytic uremic syndrome
@en-gb
Deletion of complement factor ...... ical hemolytic uremic syndrome
@nl
type
label
Deletion of complement factor ...... ical hemolytic uremic syndrome
@ast
Deletion of complement factor ...... ical hemolytic uremic syndrome
@en
Deletion of complement factor ...... ical hemolytic uremic syndrome
@en-gb
Deletion of complement factor ...... ical hemolytic uremic syndrome
@nl
altLabel
Deletion of Complement Factor ...... ical Hemolytic Uremic Syndrome
@en
prefLabel
Deletion of complement factor ...... ical hemolytic uremic syndrome
@ast
Deletion of complement factor ...... ical hemolytic uremic syndrome
@en
Deletion of complement factor ...... ical hemolytic uremic syndrome
@en-gb
Deletion of complement factor ...... ical hemolytic uremic syndrome
@nl
P2093
P2860
P50
P3181
P1433
P1476
Deletion of complement factor ...... ical hemolytic uremic syndrome
@en
P2093
Anne E Hughes
Bernd Hoppe
Christine Skerka
Christoph Licht
Danny Routledge
Heiko Richter
Joachim Misselwitz
Judith A Goodship
Lisa Strain
Matthew Edey
P2860
P3181
P356
10.1371/JOURNAL.PGEN.0030041
P407
P577
2007-03-16T00:00:00Z